Viewing StudyNCT00160082



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00160082
Status: COMPLETED
Last Update Posted: 2007-04-03
First Post: 2005-09-09

Brief Title: Efficacy and Safety of Xepol Human Immunoglobulin in Subjects With Post-Polio Syndrome PPS
Sponsor: Calliditas Therapeutics AB
Organization: Calliditas Therapeutics AB

Organization Data

Organization: Calliditas Therapeutics AB
Class: INDUSTRY
Study ID: IvIG 100
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Calliditas Therapeutics AB
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators